Can a Redness-Relief drop help glaucoma eyes without side effects?

NCT ID NCT04007276

Not yet recruiting Symptom relief Sponsor: Tulane University Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests whether Lumify, a low-dose brimonidine eye drop already approved for redness, can safely reduce eye redness and eyelid droop in 60 glaucoma patients who already use stronger brimonidine drops. Researchers will measure redness, eye pressure, and eyelid position after a single dose. The goal is to see if this lower concentration can relieve a common side effect without harming glaucoma control.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: brimonidine tartrate ophthalmic solution 0.025% (Lumify)
What this could lead to: If it works, this could offer glaucoma patients a way to reduce eye redness without raising eye pressure or causing droopy eyelids.
What could go wrong: This is a small, early-phase trial with only 60 participants. The lower dose may not work as well as expected, and individual results may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DROOPY EYELID are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glaucoma open-angle glaucoma ptosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DROOPY EYELID GLAUCOMA GLAUCOMA, OPEN-ANGLE GLAUCOMA, PRIMARY OPEN ANGLE GLAUCOMA; DRUGS PTOSIS

Can a Redness-Relief drop help glaucoma eyes without side effects?

Summary

What this could mean

Get notified about this study

Conditions

As listed by the trial registrant

Contacts and locations

Locations

More trials for these conditions